摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dimethyl (2-oxo-2-(pyridin-3-yl)ethyl)phosphonate

中文名称
——
中文别名
——
英文名称
dimethyl (2-oxo-2-(pyridin-3-yl)ethyl)phosphonate
英文别名
(2-oxo-2-pyridin-3-ylethyl)phosphonic acid dimethyl ester;dimethyl (2-oxo-2-(3-pyridyl)ethyl)phosphonate;Dimethyl 2-oxo-2-(3-pyridyl)ethylphosphonate;2-dimethoxyphosphoryl-1-pyridin-3-ylethanone
dimethyl (2-oxo-2-(pyridin-3-yl)ethyl)phosphonate化学式
CAS
——
化学式
C9H12NO4P
mdl
——
分子量
229.172
InChiKey
MYHDGAADXBYIBQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    65.5
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    dimethyl (2-oxo-2-(pyridin-3-yl)ethyl)phosphonateNLG-919中间体 在 sodium hydride 、 溶剂黄146 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 18.67h, 以89%的产率得到2-(5H-imidazo[5,1-a]isoindol-5-yl)-1-(pyridin-3-yl)ethanone
    参考文献:
    名称:
    Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1
    摘要:
    A novel class of 5-substituted 5H-imidazo[5,1-a]isoindoles are described as potent inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1). A structure-based drug design approach was used to elaborate the 5H-imidazo[5,1-a]isoindole core and to improve potency and pharmacological properties. Suitably placed hydrophobic and polar functional groups in the lead molecule allowed improvement of IDO1 inhibitory activity while minimizing off-target liabilities. Structure-activity relationship studies focused on optimizing IDO1 inhibition potency and a pharmacokinetic profile amenable to oral dosing while controlling CYP450 and hERG inhibitory properties.
    DOI:
    10.1021/acs.jmedchem.9b00662
  • 作为产物:
    描述:
    参考文献:
    名称:
    GPR52拮抗剂降低亨廷顿病水平并改善亨廷顿舞蹈病相关表型
    摘要:
    GPR52是一种孤儿G蛋白偶联受体(GPCR),最近被认为是亨廷顿氏病(HD)(一种无法治愈的单基因神经退行性疾病)的潜在药物靶标。在这项研究中,我们发现GPR52的纹状体敲低可降低成年HdhQ140小鼠的mHTT水平,从而将GPR52确认为HD靶标。此外,通过结构-活性关系(SAR)研究,我们发现了一种高效且特异的GPR52拮抗剂Comp- 43,IC 50值为0.63μM 。进一步的研究表明,Comp- 43通过靶向GPR52降低mHTT水平,并促进了小鼠原代纹状体神经元的存活。此外,体内研究表明Comp- 43不仅降低了mHTT水平,而且还挽救了HdhQ140小鼠的HD相关表型。两者合计,我们的研究证实,抑制GPR52是HD治疗的一种有前途的策略,而GPR52拮抗剂Comp- 43可能充当进一步研究的先导化合物。
    DOI:
    10.1021/acs.jmedchem.0c01133
点击查看最新优质反应信息

文献信息

  • A General Procedure for the Preparation of β-Ketophosphonates
    作者:Kevin M. Maloney、John Y. L. Chung
    DOI:10.1021/jo901552k
    日期:2009.10.2
    A mild, high-yielding procedure for the preparation of β-ketophosphonates is described. The condensation is general with respect to the ester and phosphonate, and the products are obtained in high yields within minutes at 0 °C. The reaction procedure is operationally simple and amenable to large-scale preparations.
    描述了制备β-酮膦酸酯的温和的高产率方法。对于酯和膦酸酯而言,缩合是普遍的,并且在0℃下在数分钟内以高收率获得产物。该反应程序操作简单并且适于大规模制备。
  • Organocatalytic Enantio- and Diastereoselective Construction of <i>syn</i>-1,3-Diol Motifs via Dynamic Kinetic Resolution of In Situ Generated Chiral Cyanohydrins
    作者:Akira Matsumoto、Keisuke Asano、Seijiro Matsubara
    DOI:10.1021/acs.orglett.9b00677
    日期:2019.4.19
    syn-1,3-dioxanes as protected 1,3-diols via dynamic kinetic resolution of in situ generated chiral cyanohydrins has been developed. This method involves a reversible cyanohydrin formation/hemiacetalization/intramolecular oxy-Michael addition reaction cascade, affording a chiral syn-1,3-diol structure with simultaneous construction of two stereogenic centers. The use of trifluoromethyl ketones is crucial
    已开发了一种通过原位生成的手性氰醇的动态动力学拆分方法不对称合成作为保护性1,3-二醇的合成-1,3-二恶烷的有机催化方法。该方法涉及可逆的氰醇形成/半缩醛化/分子内氧基-迈克尔加成反应级联,提供了手性合成的1,3-二醇结构,同时构建了两个立体异构中心。三氟甲基酮的使用对于有效的三组分级联反应至关重要,并且手性双官能有机催化剂在手性syn -1,3-二醇基序的形成中具有很高的对映选择性和非对映选择性。
  • Investigation of a Unified Strategy for the Synthesis of Anatoxin Analogues: Scope and Limitations
    作者:Robert Stockman、Stephen Roe、David Hughes、Pooja Aggarwal
    DOI:10.1055/s-0029-1217021
    日期:2009.11
    homoanatoxin and several analogues by a combined two-directional synthesis-tandem reaction strategy are presented. Key steps include an oxidative desymmetrisation and a tandem Michael-intramolecular Mannich cyclisation. anatoxin - homoanatoxin - two-directional - tandem - cascade - Michael - iminium - desymmetrisation
    提出了一种有效的神经毒素和生化探针anatoxin-a和homoanatoxin以及几种类似物的双向合成串联反应策略的合成。关键步骤包括氧化脱对称和串联迈克尔-分子内曼尼希环化反应。 抗毒素-高毒素-双向-串联-级联-迈克尔-亚胺鎓-解对称
  • Palladium‐Catalyzed Allylation of Vinylethylene Carbonates with <i>β</i> ‐Ketophosphonates: Stereoselective Synthesis of ( <i>Z</i> )‐Homoallylic Phosphonates
    作者:Zhigang Liu、Miaolin Ke、Ke Zhang、Zexu Wang、Baijun Ye、Fener Chen
    DOI:10.1002/cctc.202001925
    日期:2021.4.9
    A first simple palladium catalyzed allylation of vinylethylene carbonates with β‐ketophosphonates has been developed. This method provides access to (Z)‐tri‐ and tetrasubstituted homoallylic phosphonates with exclusive regioselectivity, chemoselectivity and (Z)‐stereoselectivity. The reaction tolerates a wide substrate scope of vinylethylene carbonates and β‐ketophosphonates with electron‐donating
    已经开发出第一个简单的钯催化的碳酸乙烯基亚乙酯与β-酮膦酸酯的烯丙基化反应。这种方法提供了具有独占的区域选择性,化学选择性和(Z)-立体选择性的(Z)-三和四取代均烯丙基膦酸酯。该反应可耐受具有给电子基团和吸电子基团的乙烯基碳酸亚乙酯和β-酮膦酸酯的广泛底物范围,并且在克规模上效果很好。
  • N-(3-pyridylalkyl)sulfonamide derivative and pharmaceutical preparation containing thereof
    申请人:TERUMO KABUSHIKI KAISHA
    公开号:EP0501876A1
    公开(公告)日:1992-09-02
    Illustrative examples of the N-(3-pyridylalkyl)sulfonamide derivative are represented by the following formulae [II] and [III]: The derivatives are available for a thromboxane A₂ production inhibitor, a thromboxane A₂ antagonist, a prostaglandin H₂ antagonist, an anti-thrombus agent, a thrombus-preventing agent and an anti-allergy agent.
    N-(3-吡啶基烷基)磺酰胺衍生物的举例说明如下公式[II]和[III]所示:这些衍生物可用作血栓素A₂生成抑制剂、血栓素A₂拮抗剂、前列腺素H₂拮抗剂、抗血栓剂、预防血栓剂和抗过敏剂。
查看更多